LeMaitre Vascular stock has fallen back from recent highs, but still is up just over 65% over the past 12 months. Read why I would not buy the dip in LMAT.

Investors might want to bet on LeMaitre Vascular (LMAT), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

LeMaitre Vascular (NASDAQ:LMAT) priced its offering of $150M 2.50% convertible senior notes due 2030 in a private offering.The issuance and sale of the notes is scheduled to settle on December 19 ...

Lightwave Logic, Inc. (NASDAQ: LWLG) announced today that Chief Executive Officer Yves LeMaitre will present on Wednesday, ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Georges LeMaitre (1894-1966) showed that religion and science -- or at least physics -- did not have to be incompatible. LeMaitre, born in Belgium, was a monsignor in the Catholic church.

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few ...

Andre Lemaitre was a French painter who was born in 1909. How much does an Andre Lemaitre cost? Andre Lemaitre's work has been offered at auction multiple times, with realized prices ranging from 55 ...

Nyxoah (NASDAQ:NYXH – Get Free Report) and LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on ...

LifeSpan ePTFE Vascular Grafts for peripheral vascular reconstructions and AV Access have been used in clinical practice for more than 15 years. It features soft ePTFE material with superb suture ...